CAR-T Cell Therapy in First Line for High Risk Diffuse Large B-Cell Lymphoma: Review of Efficacy and CostEffectiveness Against Standard of Care Chemo-Immunotherapy

被引：3
|
作者：
Akbar, Usman Ali [1 ]
Rashid, Zaraq [2 ]
Rehman, Zarlish [3 ]
Alam, Shehzad [4 ]
Altaf, Zooha [5 ]
Anwar, Rana Usman [6 ]
Khan, Adil [6 ]
Wakeel, Jafir [6 ]
Farooq, Saad [7 ]
Khan, Muhammad Haris [8 ]
Safi, Danish [9 ]
Inayat, Arslan [10 ]
Safi, Salah Ud Din [9 ]
机构：
[1] Northwell Hlth, Dept Internal Med, New York, NY USA
[2] LRH, Peshawar, Pakistan
[3] Hayatabad Med Complex, Peshwar, Pakistan
[4] Khyber Teaching Hosp, Peshawar, Pakistan
[5] Eastern Virginia Med Sch, Norfolk, VA 23501 USA
[6] Univ Louisville, Louisville, KY 40292 USA
[7] Nishtar Med Univ, Multan, Pakistan
[8] Univ Louisiana, Div Infect Dis, Shreveport, LA USA
[9] West Virginia Univ, Morgantown, WV 26506 USA
[10] Univ Buffalo, Buffalo, NY USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-170669
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：12052 / 12054
页数：3
相关论文
共 50 条
  • [31] CAR T-Cell Therapy in Large B-Cell Lymphoma
    Quintas-Cardama, Alfonso
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (11): : 1065 - 1065
  • [32] Management of relapsed or refractory large B-cell lymphoma in patients ineligible for CAR-T cell therapy
    Perrone, Salvatore
    Lopedote, Paolo
    Levis, Mario
    Di Rocco, Alice
    Smith, Stephen Douglas
    EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (03) : 215 - 232
  • [33] Characterization of Hemophagocytic Lymphohistio(HLH)in Relapsed Diffuse Large B-Cell Lymphoma Patients after CAR-T Therapy
    Zhou, Lili
    Ye, Shiguang
    Dang, Xiuyong
    Li, Shaoguang
    Li, Ping
    BLOOD, 2023, 142
  • [34] Circulating tumor DNA assessment in patients with diffuse large B-cell lymphoma following CAR-T therapy.
    Dahiya, Saurabh
    Le, Ryan
    Hossain, Nasheed Mohammad
    Abramian, Matthew
    Muffly, Lori S.
    Miklos, David Bernard
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [35] Efficacy of lenalidomide in high-risk diffuse large B-cell lymphoma
    Rodgers, Thomas D.
    Baran, Andrea
    Reagan, Patrick M.
    Casulo, Carla
    Zent, Clive
    Evans, Andrew
    Burack, Richard
    Williams, AnnaLynn M.
    Friedberg, Jonathan W.
    Barr, Paul M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (04) : E33 - +
  • [36] Cellular Therapy Updates in B-Cell Lymphoma: The State of the CAR-T
    Crees, Zachary D.
    Ghobadi, Armin
    CANCERS, 2021, 13 (20)
  • [37] Feasibility of CAR-T in very old patients with relapsed/refractory diffuse large B-cell lymphoma
    Rozental, Alon
    Chavez, Julio C.
    Sehovic, Marina
    Locke, Frederick L.
    Lazaryan, Aleksandr
    Nishihori, Taiga
    Khimani, Farhad
    Jain, Michael D.
    Shah, Bijal D.
    Extermann, Martine
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] Advanced laboratory techniques in diffuse large B-cell lymphoma treated with CAR-T: the role for pathologists
    Michaels, Phillip D.
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2024, 9 (01): : 25 - 28
  • [39] Characteristics of premanufacture CD8+T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma
    Wang, Yao
    Tong, Chuan
    Lu, Yuting
    Wu, Zhiqiang
    Guo, Yelei
    Liu, Yang
    Wei, Jianshu
    Wang, Chunmeng
    Yang, Qingming
    Han, Weidong
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [40] Characteristics of premanufacture CD8+ T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma
    Yao Wang
    Chuan Tong
    Yuting Lu
    Zhiqiang Wu
    Yelei Guo
    Yang Liu
    Jianshu Wei
    Chunmeng Wang
    Qingming Yang
    Weidong Han
    Signal Transduction and Targeted Therapy, 8
12345